Tonix is led by an executive team with significant industry experience in drug development. The expertise and relationships of our passionate leadership team make Tonix Pharmaceuticals’ mission possible through proprietary developments and strategic collaborations with world-class academic and non-profit research organizations.
Seth Lederman, M.D.
Co-Founder, CEO & Chairman
Gregory Sullivan, M.D.
Chief Medical Officer
Bradley Saenger, CPA
Chief Financial Officer
Jessica Edgar Morris
Chief Operating Officer
Herbert Harris, M.D., Ph.D.
Executive Vice President, Translational Medicine
Siobhan Fogarty, B.Sc., M.Sc.(QP)
Executive Vice President, Product Development
Darryl Rideout, Ph.D.
Executive Vice President, Experimental Chemistry
Bruce Daugherty, Ph.D., MBA
Executive Vice President, Research
Sina Bavari, Ph.D.
Executive Vice President, Infectious Disease Research and Development